Browse Categories

Search

Price: $298.00

Quantity:

Item Number: C11Q109

Learn the Future Viability of Risk-Sharing and Innovative Contracting in the United States

Understand how healthcare reform should require more innovation and risk-sharing deals from the pharmaceutical industry
Align products and services with desired health outcomes and reimbursement structures
Create a win-win strategy through co-pay offset programs for appropriate use
Evaluate financial-based agreements versus outcomes-based agreements
Translate successful European innovative contract agreements into actionable opportunities for the U.S. marketplace
Determine where in the drug development process an innovative contracting agreement should be considered

(0 Ratings, 0 Reviews)

Books purchased from Advanstar Communications Inc. may be returned for a refund subject to the following conditions:... Read More...

Advanstar Communications Inc. ("Advanstar") has created this privacy statement to demonstrate our firm commitment...
Read More...